These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28722334)

  • 1. Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol.
    Mokhtari F; Bostakian A; Shahmoradi Z; Jafari-Koshki T; Iraji F; Faghihi G; Hosseini SM; Bafandeh B
    J Cosmet Dermatol; 2018 Apr; 17(2):165-170. PubMed ID: 28722334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study.
    Anbar TS; Westerhof W; Abdel-Rahman AT; Ewis AA; El-Khayyat MA
    Photodermatol Photoimmunol Photomed; 2008 Dec; 24(6):322-9. PubMed ID: 19000191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of periungual vitiligo with erbium-YAG-laser plus 5-flurouracil: a left to right comparative study.
    Anbar T; Westerhof W; Abdel-Rahman A; El-Khayyat M; El-Metwally Y
    J Cosmet Dermatol; 2006 Jun; 5(2):135-9. PubMed ID: 17173588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo.
    Yan R; Yuan J; Chen H; Li YH; Wu Y; Gao XH; Chen HD
    Lasers Med Sci; 2017 Sep; 32(7):1571-1577. PubMed ID: 28710660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
    Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
    Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata.
    Shokeir HA; Yousry A; Ibrahim SMA
    Arch Dermatol Res; 2023 Mar; 315(2):241-247. PubMed ID: 36264329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon dioxide laser plus topical 5-fluorouracil: a new combination therapeutic modality for acral vitiligo.
    Mohamed HA; Mohammed GF; Gomaa AH; Eyada MM
    J Cosmet Laser Ther; 2015; 17(4):216-23. PubMed ID: 25549816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.
    Kanokrungsee S; Chanprapaph K; Chaiyabutr C; Vachiramon V
    Lasers Med Sci; 2016 Sep; 31(7):1343-9. PubMed ID: 27291387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Factors Associated With Efficacy and Adverse Events of Fractional Erbium:YAG Laser-Assisted Delivery of Topical Betamethasone for Stable Vitiligo: A Retrospective Analysis.
    Huang C; Li P; Wang B; Deng Y; Li J; Mao M; Jian D
    Lasers Surg Med; 2020 Sep; 52(7):590-596. PubMed ID: 31820470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 17. Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1,064/532 nm), cryotherapy and chemical peels: A comparative study.
    El-Mofty M; Mostafa WZ; Esmat S; Zayed A; Mashaly H; Hussien MF; Ismail SI
    Dermatol Ther; 2019 Sep; 32(5):e13052. PubMed ID: 31376312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata.
    Jung KE; Gye JW; Park MK; Park BC
    Int J Dermatol; 2017 Dec; 56(12):1487-1488. PubMed ID: 28703306
    [No Abstract]   [Full Text] [Related]  

  • 19. 2940-nm Er:YAG fractional laser enhanced the effect of topical drug for psoriasis.
    Li R; Zhou J; Su H; Wang M; Wang Y; Xiao S; Ma H
    Lasers Med Sci; 2017 Aug; 32(6):1393-1397. PubMed ID: 28646390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.